Virpax inks ‘patch-in-a-can’ deal for pain management

By Flora Southey

- Last updated on GMT

MedPharm's MedSpray 'patch-in-a-can' technology
MedPharm's MedSpray 'patch-in-a-can' technology
Virpax Pharmaceuticals has licensed MedPharm’s topical spray technology to develop a transdermal patch for non-opioid pain management products.

Under the agreement, US-based Virpax will develop an investigational spray film designed to deliver nonsteroidal anti-inflammatory drug (NSAID) DSF100 using MedPharm’s metered-dose spray, MedSpray. Financial terms were not disclosed.

The metered-dose aerosol spray – which MedPharm describes as a ‘patch-in-a-can’ – forms a thin film on the skin or mucosal membrane, enabling the transdermal delivery of NSAIDs.  

According to UK-headquartered MedPharm, the technology “features a high level of adhesiveness, accessibility and skin drying.”

In addition, “compared to a standard topical spray MedSpray gives extended release and compared to a standard patch MedSpray is invisible,” ​the spokesperson told us.

The US Food and Drug Administration granted a pre-investigational new drug meeting request for DSF100 in May this year.

Virpax is exploring other transdermal drug delivery technologies for pain management. Last month​, the US firm signed a license agreement for LipoCure’s long-active liposomal gel, to develop anaesthetics for post-operative pain.

“We believe there is an opportunity to explore the development of non-opioid transdermal pain treatments that improve on existing gel and patch products, for which adhesion and accessibility can be a challenge,”​ said Virpax CEO Anthony Mack in a statement​.

Related topics Drug Delivery Delivery technologies

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers